Contact information
adan.pintofernandez@ndm.ox.ac.uk
CAMS Oxford Institute, Old Road Campus, University of Oxford
Adán Pinto-Fernández
Career Development Fellow at Chinese Academy of Medical Sciences Oxford Institute
TRANSLATIONAL STUDIES OF THE UBIQUITIN SYSTEM - CANCER IMMUNOLOGY
Current research involves the study of the roles of a class of druggable enzymes called deubiquitylating enzymes (DUBs) in cancer inflammation using advanced proteomics, lipidomics, and immunology techniques as main tools.
For instance, we have recently discovered that cancer cells lacking the DUB USP18, a negative regulator of the interferon pathway, are more antigenic and radiosensitive. At a molecular level, USP18-deficient cells accumulate innate immune ligands such as dsRNA, enhance the antigen presentation machinery, and hence they can activate more efficiently cytotoxic T cells, resulting in enhanced T cell killing and immunotherapy responses. Read more here.
Recent publications
-
Identification of a newPlasmodium falciparumE2 ubiquitin conjugating enzyme
Preprint
Smith C. et al, (2024)
-
USP24 is an ISG15 cross-reactive deubiquitinase that mediates IFN-I production by de-ISGylating the RNA helicase MOV10
Preprint
Mukhopadhyay R. et al, (2024)
-
Deubiquitinases in muscle physiology and disorders
Journal article
Olie CS. et al, (2024), Biochemical Society Transactions, 52, 1085 - 1098
-
Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1
Journal article
Imhoff RD. et al, (2024), Journal of Medicinal Chemistry, 67, 4496 - 4524
-
USP16 is an ISG15 cross-reactive deubiquitinase targeting a subset of metabolic pathway-related proteins
Preprint
Gan J. et al, (2023)